Tagged with Fact

Takeda The Japan-based company is changing into a new Takeda. José Manuel Caamaño, general manager of Takeda Mexico, talks about the transformation process the company is going through to become a best-in-class organization. The company’s five-year aim is to be recognized as a best employer in Mexico keeping the values and…

contract manufacturing The chairman of contract manufacturer Korea Pharma discusses the Korean CMO market and incremental innovation.   Where did your idea for starting Korea Pharma come from? I am a pharmacist by training, and graduated from Yeong-nam University’s college of pharmacy. After graduation, I worked for Seoul Pharmaceutical Company for five…

R&D The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its exciting research on a radically new oncology platform. Today, Eriochem is a vertically integrated company producing both APIs and final dosage forms; when you started the company, what was the strategy you followed…

manufacturing The president of Algeria’s union for pharmaceutical operators discusses the state of the local industry and sheds light on the sets of challenges his members (both importers and domestic manufactures) face under the current context. The state expects a radical change in Algeria’s production makeup, with 70 percent of drug needs…

manufacturing The founder of one of Algeria’s pioneer pharmaceutical manufacturers tells his story about how he guided his company up the value chain having originally started off by undertaking the packaging component before moving on to  more complex forms. He also discusses the ‘made in Algeria’ brand and the challenges of sourcing skilled…

manufacturing Merck is getting “Fit for 2018”. Pedro Galvis, the company’s managing director for Mexico, discusses how the company’s transformation program, implemented in 2012, is ensuring future growth and how Mexico’s manufacturing cost competitiveness has driven further investment in production capacities. What is the major challenge that R&D-driven multinational companies face…

manufacturing The CEO recounts the rise of one of Algeria’s home grown success stories, analyses the future of the local para-pharmaceutical market and explains how attitudes and customs are changing with issues like adult incontinence no longer taboo topics. Can you introduce FADERCO, its evolution, investments and achievements to date? FADERCO’s…

manufacturing The country manager for Algeria discusses how the company was the first foreign entity to engage in local manufacturing and sheds light on some of the difficulties in introducing innovative molecules to the market. Pfizer was one of the first multinationals to engage with the Algerian pharmaceuticals market and enjoys…

manufacturing The Managing Director for North West Africa outlines his philosophy of technology transfer and the importance of involving local content in ‘fill-and-finish’ manufacturing so that the host country is empowered to scale the value chain. Can you please start by introducing Merck in North Africa and in particular Algeria? Merck…

manufacturing The CEO of one of Algeria’s most successful pharmaceutical firms describes how El Kendi became the first foreign firm to be established in Algeria without having a mother company abroad. He also lifts the lid on the secrets behind the firms extraordinary track record for speed in securing product registration and approval on…

heparin The vice president of Laboratorio Tuteur highlights the position of his company as the leaders in specialty products in Argentina.   Could you please give us an historical overview of Laboratorio Tuteur S.A.C.I.F.I.A., a company with more than 40 years of history? Laboratorio Tuteur S.A.C.I.F.I.A. is a company based in Argentina…

Novo Nordisk The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian market is so strategically important and how the ‘made in Algeria’ brand would have real potential at the regional level if only the government would remove impediments to export. As COO of Novo…